bpc 157 fda approved status 2025 Peptide Reclassification 2026 BREAKING: The FDA just reversed
Description
Colletti, A., & Cicero, A
There was no blinding, there was no control group, and there were no validated questionnaires
Thompson WG, Cassino C, Babitz L, et al
doi: 10.1016/0165-0327(95)00026-J 443 MisiakBoniewskiIMarliczWFrydeckaDSzulcARudzkiLet al
Today, it refers specifically to B12 deficiency anemia resulting from antibodies that inhibit B12 absorption
